Vaccine

Pharmaceutical Quality Management Systems Market to Be Worth $4.59 Billion by 2031 – Exclusive Report by Meticulous Research®

REDDING, Calif., July 15, 2024 /PRNewswire/ -- According to a new market research report titled, 'Pharmaceutical Quality Management Systems Market Size,…

1 year ago

NanoPass Technologies Secures Awz Ventures’ $4M Investment, Signaling Growth and Innovation in Intradermal Delivery Technology

NESS ZIONA, Israel, July 15, 2024 /PRNewswire/ -- NanoPass Technologies, a leading innovator in intradermal delivery solutions, has secured a $4…

1 year ago

Modicus Prime Raises $3.5M to prevent Drug Product Quality failures during Commercial Production

Modicus Prime, the AI image processing platform for drug manufacturing, is addressing the cost, legal, and waste liabilities caused by…

1 year ago

Teknova Announces Closing of $15.4 Million Private Placement

HOLLISTER, Calif., July 12, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents…

1 year ago

Inhance Technologies’ Statement in Response to EPA’s Section 6 Approach on Fluorination of Plastic Containers

HOUSTON, July 12, 2024 /PRNewswire/ -- Inhance Technologies welcomes the opportunity to engage with the United States Environmental Protection Agency…

1 year ago

ImmuneAGE Bio launches to rejuvenate the immune system targeting bone marrow stem cells

SAN JUAN, Puerto Rico and LAUSANNE, Switzerland, July 12, 2024 /PRNewswire/ -- ImmuneAGE Bio raised $2M and has built the…

1 year ago

FluGen’s Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults Shows Superiority Over Flu Shot Alone

– Findings reported today in the journal Lancet Infectious Diseases– Study shows synergistic immunological response generated by M2SR and Fluzone High…

1 year ago

Teknova Announces $15.4 Million Private Placement

HOLLISTER, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents…

1 year ago

CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech

New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas TherapeuticsFirst instance decision on…

1 year ago

Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024

CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live…

1 year ago